It is this size and broad global footprint that enables Accord to manufacture and deliver vital, affordable medicines to healthcare providers and patients in over 85 countries around the world. The company’s rapidly expanding product portfolio now comprises over 8,500 approved products spanning critical therapeutic fields such as oncology, cardiology, neurology, psychiatry, diabetes, pain management and gastroenterology.